PWM
BIO icon

Parkworth Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Parkworth Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$241 Buy
+1
New +$236 ﹤0.01% 887
2025
Q1 		– Sell
-1
Closed -$329 – 1236
2024
Q4 		$329 Buy
+1
New +$339 ﹤0.01% 578

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Parkworth Wealth Management's BIO Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2025: 1 share worth $241. The stake represents ﹤0.01% of the portfolio and ranks #887 among its holdings. This is a return to the name: Parkworth Wealth Management previously reported a position in BIO as recently as Q4 2024.

Parkworth Wealth Management first reported a position in BIO in Q4 2024 and has held it in 2 quarters since. The position peaked at $329 in Q4 2024. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Parkworth Wealth Management held 1 share of Bio-Rad Laboratories Class A worth $241 as of Q2 2025.
  • Bio-Rad Laboratories Class A was a new Parkworth Wealth Management position in Q2 2025.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #887 holding.
  • Parkworth Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 2 quarters since.
  • Parkworth Wealth Management's Bio-Rad Laboratories Class A position peaked at $329 in Q4 2024.
  • 383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.